Investigating potential drug targets for Alzheimer's disease
TREAT AD Structural Biology Core
['FUNDING_OTHER'] · EMORY UNIVERSITY · NIH-10954114
This study is working on creating helpful tools and information for scientists to find new ways to treat Alzheimer's disease by understanding how certain proteins work and how they might interact with potential medications.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-10954114 on ClinicalTrials.gov |
What this research studies
This research focuses on developing experimental tools and knowledge to help scientists explore potential drug targets for Alzheimer's disease. It involves creating Target Enabling Packages (TEPs) that include gene knockout reagents, cell lines, and purified proteins for functional studies. The project aims to provide structural data and support drug development by characterizing proteins and their interactions with small molecules. By sharing these resources, the research promotes collaboration within the biomedical community to advance Alzheimer's treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for or diagnosed with Alzheimer's disease.
Not a fit: Patients with other forms of dementia or cognitive impairment unrelated to Alzheimer's may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective therapies for Alzheimer's disease.
How similar studies have performed: Other research has shown success in using structural biology approaches to identify drug targets, indicating a promising avenue for this project.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LEVEY, ALLAN I — EMORY UNIVERSITY
- Study coordinator: LEVEY, ALLAN I
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.